Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin

Karthik Viswanathan, Xiaoying Koh, Aarthi Chandrasekaran, Claudia Pappas, Rahul Raman, Aravind Srinivasan, Zachary Shriver, Terrence M. Tumpey, Ram SasisekharanPLoS 2010 · DOI

Abstract

The H2N2 influenza A virus subtype was responsible for the 1957-58 Asian pandemic but ceased human circulation in 1968. With waning global immunity, the potential re-emergence of H2 strains from avian reservoirs is a significant public health concern. A critical step in cross-species transmission is the adaptation of the viral hemagglutinin (HA) to human-type glycan receptors (α2-6-linked sialic acids). This study investigates the molecular determinants of this specificity switch in modern avian H2N2 strains, which have diverged significantly from the 1957 pandemic ancestor. Using structural modeling and quantitative binding assays, we identify a set of mutations—specifically at positions 137 and 193—that, in combination with classic mutations at 226 and 228, confer human-like receptor affinity to contemporary avian H2N2 HA.

Introduction

Influenza pandemics occur when a novel virus to which humans have little immunity jumps from an animal reservoir. The H2N2 pandemic of the late 1950s is a prime example. While H1N1 and H3N2 subtypes continue to circulate, H2N2 has been absent for over five decades, leaving individuals born after 1968 immunologically naive. Because H2 subtypes remain endemic in birds and occasionally infect pigs, the risk of a "shift" or "drift" event leading to human re-infection is constant.

The primary barrier to this jump is the HA protein's receptor binding specificity. Avian viruses typically target α2-3-linked sialic acids in the bird gut, whereas human-adapted viruses target α2-6-linked sialic acids in the upper respiratory tract. Understanding the exact mutations required for this switch in modern avian backgrounds is essential for effective genomic surveillance.

Methods and Materials

The research team utilized a multi-disciplinary approach to map the binding landscape of H2N2:

  • Quantitative Glycan Array Binding: The researchers employed a dose-dependent platform to calculate an apparent binding constant ($K_d'$), accounting for the multivalent nature of viral attachment.
  • Human Tissue Staining: Recombinant HA proteins were applied to human tracheal and alveolar tissue sections to validate array results in a biological context.
  • Homology Modeling: 3D models of HA from a 2004 chicken isolate (CkPA04) were constructed using PDB templates (2WR7, 2WR2) to visualize structural interactions.
  • Site-Directed Mutagenesis: Mutations were systematically introduced into the CkPA04 HA to transform its binding profile to match the 1957 pandemic reference strain (Alb58).

Results

A key finding was that the pandemic Alb58 HA is a "generalist," maintaining high affinity for human receptors while retaining significant binding to avian receptors. In contrast, the baseline avian strain CkPA04 showed negligible human receptor binding.

Interestingly, introducing the "classic" mutations at positions 226 and 228 (the LS mutant) into the modern avian background only partially restored human binding. The resulting affinity ($K_d' \approx 50$ pM) was nearly 10-fold weaker than that of the Alb58 strain ($K_d' \approx 5$ pM).

Figure 1: Binding of the pandemic Alb58 HA to human respiratory tissues. The green fluorescence indicates HA binding to the apical surface of the trachea (upper airway) and the alveolar walls (deep lung).

The study identified that additional mutations at positions 137 (Gln → Arg) and 193 (Ala → Thr) were necessary to bridge this gap. These residues are located on the periphery of the binding pocket and interact with the glycan chain beyond the initial sialic acid linkage. The triple mutant (TLS: 193+226+228) and quadruple mutant (RTLS: 137+193+226+228) successfully boosted human receptor affinity to the 3–8 pM range, matching the pandemic strain's performance.

Tissue staining confirmed these results. While the wild-type avian HA primarily stained the deep lung (alveoli), the human-adapted RTLS mutant showed extensive staining on the apical surface of the human trachea, a hallmark of viruses capable of human-to-human transmission.

Discussion and Conclusion

This research highlights that sequence divergence in modern avian strains necessitates a more complex set of mutations for human adaptation than previously thought. The identification of residues 137 and 193 as critical determinants provides a specific "watchlist" for public health officials monitoring avian influenza.

While these findings demonstrate the biochemical potential for human adaptation, further research is needed to determine if these mutations also support efficient viral replication and aerosol transmission in vivo. Nevertheless, this study significantly advances our ability to assess the pandemic risk posed by circulating H2N2 avian influenza viruses.

Summary updated

Abstract

The H2N2 subtype of influenza A virus was responsible for the Asian pandemic of 1957-58. However, unlike other subtypes that have caused pandemics such as H1N1 and H3N2, which continue to circulate among humans, H2N2 stopped circulating in the human population in 1968. Strains of H2 subtype still continue to circulate in birds and occasionally pigs and could be reintroduced into the human population through antigenic drift or shift. Such an event is a potential global health concern because of the waning population immunity to H2 hemagglutinin (HA). The first step in such a cross-species transmission and human adaptation of influenza A virus is the ability for its surface glycoprotein HA to bind to glycan receptors expressed in the human upper respiratory epithelia. Recent structural and biochemical studies have focused on understanding the glycan receptor binding specificity of the 1957-58 pandemic H2N2 HA. However, there has been considerable HA sequence divergence in the recent avian-adapted H2 strains from the pandemic H2N2 strain. Using a combination of structural modeling, quantitative glycan binding and human respiratory tissue binding methods, we systematically identify mutations in the HA from a recent avian-adapted H2N2 strain (A/Chicken/PA/2004) that make its quantitative glycan receptor binding affinity (defined using an apparent binding constant) comparable to that of a prototypic pandemic H2N2 (A/Albany/6/58) HA.
BibTeX
@inproceedings{viswanathan2010determinants,
  author = {Karthik Viswanathan and Xiaoying Koh and Aarthi Chandrasekaran and Claudia Pappas and Rahul Raman and Aravind Srinivasan and Zachary Shriver and Terrence M. Tumpey and Ram Sasisekharan},
  title = {{Determinants of Glycan Receptor Specificity of H2N2 Influenza A Virus Hemagglutinin}},
  booktitle = {PLoS},
  year = {2010},
  doi = {10.1371/journal.pone.0013768},
}
Figure